Preview

Research and Practical Medicine Journal

Advanced search

THE POSSIBILITIES OF TREATMENT OF PATIENTS WITH MALIGNANT NEOPLASMS OF THE FEMALE REPRODUCTIVE SYSTEM WITH METASTATIC BRAIN LESION

https://doi.org/10.17709/2409-2231-2016-3-3-2

Abstract

Literature review over the last 10 years suggests that the brain is a rare target of metastasis of neoplasms of female reproductive system. However, over the past 20 years, incidence of secondary brain damage increased 6.5 times. Genital tumor metastasis in the brain is around 5%. The optimal treatment strategy of intracerebral metastases in this case is still an unsolved problem: the presence of foci of more than 3 cm surgery and then chemotherapy and radiation therapy is recommended; with smaller foci method of choice is a stereotactic brain radiosurgery followed by chemotherapy.

Purpose. The Union of our own experience of treatment of patients with ovarian cancer (OC), cervical cancer (СС) and endometrial cancer (EC) with brain metastases and data from literature to develop the tactics of conducting patients with these diseases.

 

Patients and methods. The neurosurgical department of P. Hertsen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia from 2007 to 2016 we treated 9 patients with metastatic OC in the brain, 6 patients with metastatic ER, 4 patients with metastatic cervical cancer.

Resuts. Patients received microsurgical removal of metastatic tumors of the brain, followed by complex treatment, so they achieved a high median overall survival: patients with metastatic ovarian cancer - 14.0 months with diseasefree survival of 9.4 months. The survival median of patients with metastatic ER and cervical cancer was significantly lower, amounting to only 5.4 months.

Conclusion. The article presents modern views on the problem of treating patients with intracranial metastases of malignant tumors of the female reproductive system. Our experience demonstrates that a comprehensive treatment, including neurosurgery, leads to increased survival of patients, providing a satisfac tory quality of life.

About the Authors

A. M. Zaytsev
P. Hertsen Moscow Oncology Research Institute-Branch, National M edical Radiology Research Center, Ministry of Health of Russia; 3, 2 nd Botkinskiy proezd, Moscow, 125284, Russia
Russian Federation
PhD, head of neurosurgical department, P. Hertsen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia


E. G. Novikova
P. Hertsen Moscow Oncology Research Institute-Branch, National M edical Radiology Research Center, Ministry of Health of Russia; 3, 2 nd Botkinskiy proezd, Moscow, 125284, Russia
Russian Federation

MD, professor, head of the gynecological department of the Division of tumors of reproductive and urinary organs, P. Hertsen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia



O. N. Kirsanova
P. Hertsen Moscow Oncology Research Institute-Branch, National M edical Radiology Research Center, Ministry of Health of Russia; 3, 2 nd Botkinskiy proezd, Moscow, 125284, Russia
Russian Federation
junior researcher of neurosurgical department, P. Hertsen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia


M. I. Kurzhupov
P. Hertsen Moscow Oncology Research Institute-Branch, National M edical Radiology Research Center, Ministry of Health of Russia; 3, 2 nd Botkinskiy proezd, Moscow, 125284, Russia
Russian Federation
PhD, researcher of neurosurgical department, P. Hertsen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia


E. A. Potapova
P. Hertsen Moscow Oncology Research Institute-Branch, National M edical Radiology Research Center, Ministry of Health of Russia; 3, 2 nd Botkinskiy proezd, Moscow, 125284, Russia
Russian Federation
neurologist of neurosurgical department, P. Hertsen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia


References

1. Loshakov V. A. Intrakranial’nye metastaticheskie opukholi: Klinicheskaya nevrologiya. [Intracranial metastatic tumors: clinical neurology]. Edited by Konovalov A. N. 2005. Vol. III. Part 1. Chapter 20.2. pp. 402–8. (In Russian).

2. Zaytsev A. M., Kurzhupov M. I., Potapova E. A., Kirsanova O. N. Treatment of metastatic brain lesion. Research’n Practical Medicine Journal. 2015;2 (2):8–14. DOI:10.17709/2409–2231–2015–2-2–8-14 (In Russian).

3. Disibio G., French S. W. Metastatic patterns of cancers: results from the large autopsy study. Arch Path Lab Med. 2008;132:931–939. DOI: 10.1043/1543–2165(2008)132[931:MPOCRF]2.0.CO;2.

4. NCCN clinical practice guidelines in Oncology. Central Nervous System Cancers, version I.2013

5. Chen P. G., Lee Shih-Yuan, Barnett G. H., Vogelbaum M. A., Saxton J. P., Fleming P. A., Suh J. H. Use of the radiation therapy oncology group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma. Cancer. 2005;104 (10). DOI: 10.1002/cncr.21472.

6. Kaprin A. D., Starinskij V. V., Petrova G. V. Zlokachestvennye novoobrazovaniya v Rossii v 2013 godu [Malignancies in Russia in 2013 (morbidity and mortality)]. Moscow, 2015. Available at: http://www.oncology.ru/service/statistics/malignant_tumors/2013.pdf (Accessed 27.03.2016) (In Russian).

7. Davydov M. I., Aksel’ E. M. Zlokachestvennye novoobrazovaniya v Rossii i stranakh SNG v 2001 g. [Malignancies in Russia and the CIS countries in 2001]. Moscow: “Meditsinskoe informativnoe agentstvo” Publ., 2003. (In Russian).

8. Kawamura D., Tanaka T., Fuga M., Yanagisawa T., Tochigi S., Irie K., et al. Slow progression of calcified cerebellar metastasis from ovarian cancer: a case report and review of the literature. Neurol Med Chir (Tokyo). 2013;53 (10):722–6. DOI: 10.1155/2015/936260.

9. Rotin D. L. Clinico-morphological and molecular-biological aspects of cerebral metastases development. Problems of Neurosurgery named after N. N. Burdenko. 2012;2:70–6. (In Russian).

10. Geisler J. P., Geisler H. E. Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol. 1995;57:246–9. DOI: 10.1186/1471–2407–14–543.

11. Cormio G., Maneo A., Colamaria A., Loverro G., Lissoni A., Selvaggi L. Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases. Gynecol Oncol. 2003;89:116–9. DOI: http://dx.doi.org/10.1016/S0090–8258(03)00060‑X.

12. Cohen Z. R., Suki D., Weinberg J. S., Marmor E., Lang F. F., Gershenson D. M., et al. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neurooncol. 2004;66:313–25. DOI: 10.1023/B:NEON.0000014516.04943.38.

13. Kumar L., Barge S., Mahapatra A. K., Thulkar S., Kishore G., Kumar S., et al. Central nervous system metastases from primary epithelial ovarian cancer. Cancer Control. 2003;3:244–53. DOI:10.3109/01443615.2012.693981. Available at: https://www.moffitt.org/File%20Library/Main%20Nav/Research%20and%20Clinical%20Trials/Cancer%20Control%20Journal/v10n3/244.pdf.

14. Kolomainen D. F., Larkin J. M., Badran M., A’Hern R. P., King D. M., Fisher C., et al. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol. 2002;20:982–6. DOI: 10.1200/JCO.20.4.982.

15. Tay S. K., Rajesh H. Brain metastases from epithelial ovarian cancer. Int J Gynecol Cancer. 2005;15 (5):824–9. DOI: 10.1111/j.1525–1438.2005.00143.x.

16. Rodriguez G. C., Soper J. T., Berchuck A., Oleson J., Dodge R., Montana G., et al. Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy and surgery. J Clin Oncol. 1992;10:1553–60. DOI: 10.1016/0090–8258(92)90611‑L.

17. Corn B. W., Greven K. M., Randall M. E., Wolfson A. H., Kim R. Y., Lanciano R. M. The efficacy of cranial irradiation in ovarian cancer metastatic t the brain: analysis of 32 cases. Obstet Gynecol. 1995;86:955–9. DOI: 10.1016/0029–7844(95)00320‑Q.

18. Kaminsky-Forrett M. C., Weber B., Conroy T., Spaeth D. Brain metastase from epithelial ovarian carcinoma. Int J Gynecol Cancer. 2000;10:366–71. DOI: 10.1046/j.1525–1438.2000.010005366.x.

19. Anupol N., Ghamande S., Odunsi K., Driscoll D., Shashikant L. Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol Oncol. 2002;85:487–92. DOI: 10.1006/gyno.2002.6653.

20. Pectasides D., Aravantinos G., Fountzilas G., Kalofonos C., Efstathiou E., Karina M., et al. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature. Anticancer Res. 2005;25 (5):3553–8. DOI: 10.1634/theoncologist.11–3-252.

21. McMeekin D. S., Kamelle S. A., Vasilev S. A., Tillmanns T. D., Gould N. S., Scribner D. R., et al. Ovarian cancer metastatic to the brain: what is the optimal management? J Surg Oncol. 2001;78:194–201. DOI: 10.1002/jso.1149.

22. LeRoux P. D., Berger M. S., Elliott J. P., Tamimi HK. Cerebral metastases from ovarian carcinoma. Cancer. 1991;67:2194–9. Available at: http://onlinelibrary.wiley.com/doi/10.1002/1097-0142 (19910415)67:8<2194:: AID-CNCR2820670832>3.0.CO;2-%23/pdf.

23. Chen Y. L., Cheng W. F., Hsieh C. Y., Chen C. A. Brain metastasis as a late manifestation of ovarian carcinoma. Eur J Cancer Care (Engl). 2011;20 (1):44–9. DOI: 10.1111/j.1365–2354.2009.01133.x.

24. Longo R., Platini C., Eid N., Elias-Matta C., Buda T., ‘Nguyen D., et al. A late, solitary brain metastasis of epithelial ovarian carcinoma. BMC Cancer. 2014;14:543. DOI: 10.1186/1471–2407–14–543.

25. Chen P. G., Lee S. Y., Barnett G. H., Vogelbaum M. A., Saxton J. P., Fleming P. A., et al. Use of the Radiation Therapy Oncology Group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma. Cancer. 2005;104:2174–80. DOI: 10.1002/cncr.21472.

26. Zaĭtsev A. M., Kurzhupov M. I., Samarin A. E., Kirsanova O. N. Results of treatment in patients with metastatic brain involvement. Onkologiya. Zhurnal imeni P. A. Gertsena. 2014;3:4–10. (In Russian).

27. Shaw E., Scott C., Souhami L, Dinapoli R., Kline R., Loeffler J., et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. J Radiat Oncol Biol Phys. 2000;47:291–8. DOI: 10.1016/S0360–3016(99)00507–6

28. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA. 2006;295:2483– 91. DOI: 10.1001/jama.295.21.2483

29. Ogino A., Hirai T., Fukushima T., Serizawa T., Watanabe T., Yoshino A., et al. Gamma knife surgery for brain metastases from ovarian cancer. Acta Neurochir (Wien). 2012 Sep;154 (9):1669–77. DOI: 10.1007/s00701–012–1376–3

30. Ilialov S. R. Stereotaksicheskaya radiokhirurgiya vnutrimozgovykh metastazov raka s primeneniem ustanovki gamma-nozh. [Stereotactic radiosurgery of intracranial metastases with Gamma Knife installation]. Dissertation, 2008. (In Russian).

31. Da Silva A. N., Nagayama K., Schlesinger D., Sheehan J. P. Early brain tumor metastasis reduction following Gamma Knife surgery. J Neurosurg. 2009;110:547–52. DOI: 10.3171/2008.4.17537.

32. Murray K. J., Scott C., Greenberg H. M., Emami B., Seider M., Vora N. L., et al. A randomized phase III study of accelerated hyperfractionation versusstandard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys. 1997;39:571–4. DOI: 10.1016/S0360–3016(97)00341–6.

33. Melichar B., Urminska H., Kohlova T., Nova M., Cesak T. Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature. Gynecol Oncol. 2004;94:267–76. DOI: 10.1016/j.ygyno.2004.05.026.

34. Sehouli J., Pietzner K., Harter P., Mu¨nstedt K., Mahner S., Hasenburg A., et al. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Annals of Oncology. 2010;21 (11):2201–5. DOI:10.1093/annonc/mdq229.

35. Orrru S., Lay G., Dessi M., Murtas R., Deidda M. A., Amichetti M. Brain metastases from endometrial carcinoma: report of 3 cases and review of the literature. Tumori. 2007;93:112–7. Available at: http://www.tumorijournal.com/article/brain-metastases- from-endometrial-carcinoma – report-of-three-cases-and-review-of-the-literature.

36. De Porre P. M., Subandono Tjokrowardojo A. J. Brain metastases of endometrial carcinoma. Case report and review of literature. Strahlenther Onkol. 1992;168:100–101.

37. Gien L. T., Kwon J. S., D’Souza D. P., Radwan J. S., Hammond J. A., Sugimoto A. K., et al. Brain metastases from endometrial carcinoma: a retrospective study. Gynecol Oncol. 2004;93:524–8. DOI: 10.1016/j.ygyno.2004.02.006.

38. Martinez-Manas R. M., Brell M., Rumia J., Ferrer E. Brain metastases in endometrial carcinoma. Gynecol Oncol. 1998;70:282–4. DOI: 10.1006/gyno.1998.5021.

39. Petru E., Lax S., Kurschel S., Gucer F., Sutter B. Long-term survival in a patient with brain metastases preceding the diagnosis of endometrial cancer. Report of 2 cases and review of the literature.J Neurosurg. 2001;94:846–8. DOI: 10.3171/jns.2001.94.5.0846.

40. Ruelle A., Zuccarello M., Andrioli G. Brain metastasis from endometrial carcinoma. Report of 2 cases. Neurosurg Rev. 1994;17:83– 7. DOI: 10.5402/2012/581749.

41. Wronski M., Zakowski M., Arbit E., Hoskins W. J., Galicich J. H. Endometrial cancer metastasis to brain: report of 2 cases and a review of the literature. Surg Neurol. 1993;39:355–9.

42. Piura E, Piura B. Brain metastases from endometrial carcinoma. ISRN Oncol. 2012;2012:581749. DOI: 10.5402/2012/581749.

43. Mahmoud-Ahmed A. S., Suh J. H., Barnett G. H., Webster K. D., Belinson J. L., Kennedy.AW. The effect of radiation therapy on brain metastases from endometrial carcinoma: a retrospective study. Gynecol Oncol. 2001;83:305–9. DOI: 10.1006/gyno.2001.6384.

44. Monaco E. 3rd, Kondziolka D., Mongia S., Niranjan A., Flickinger J. C., Lunsford L. D. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer. 2008 Nov 1;113 (9):2610–4. DOI: 10.1002/cncr.23868.

45. Piura E., Piura B. Brain metastases from cervical carcinoma: overview of pertinent literature. Eur J Gynaecol Oncol. 2012;33 (6):567–73. DOI: 10.1700/1660.18186.

46.


Review

For citations:


Zaytsev A.M., Novikova E.G., Kirsanova O.N., Kurzhupov M.I., Potapova E.A. THE POSSIBILITIES OF TREATMENT OF PATIENTS WITH MALIGNANT NEOPLASMS OF THE FEMALE REPRODUCTIVE SYSTEM WITH METASTATIC BRAIN LESION. Research and Practical Medicine Journal. 2016;3(3):17-29. (In Russ.) https://doi.org/10.17709/2409-2231-2016-3-3-2

Views: 1097


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2410-1893 (Online)